{"transactions":[{"id":1176747,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T01:41:34.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":316352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth (1/16) of the shares subject to the option vested and became exercisable on April 4, 2025, with the remainder scheduled to vest and become exercisable in fifteen (15) equal quarterly installments on each July 15, October 15, January 15, and April 15 thereafter, vesting fully on January 15, 2029, in each case, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":316352,"derivative":{"exercise_price":1.02,"expiration_date":"2035-04-03","underlying":"Common Stock","underlying_shares":316352},"source":{"system":"sec-edgar","filing":"0001641172-25-003095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003095/ownership.xml","form_type":"4"}},{"id":1337302,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T14:00:05.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":254433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options vest immediately on the date of the grant."}],"balance_after":254433,"derivative":{"exercise_price":1.56,"expiration_date":"2034-12-08","underlying":"Common Stock","underlying_shares":254433},"source":{"system":"sec-edgar","filing":"0001493152-24-049381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224049381/ownership.xml","form_type":"4"}},{"id":1761873,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-11T21:25:20.000Z","date":"2023-10-06","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as follows: ratably in 16 quarterly installments (37,500 per installment) on the first day of each calendar quarter commencing with January 1, 2024, such that option will be full vested on October 1, 2027."}],"balance_after":600000,"derivative":{"exercise_price":3.0271,"expiration_date":"2033-10-05","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-23-052650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000120919123052650/doc4.xml","form_type":"4"}},{"id":2157315,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option - Option to buy","published_at":"2022-09-16T18:00:32.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":1326000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 58,105 shares of Syros common stock for $7.53 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 58,105 shares of Syros common stock for $7.53 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":0.33,"expiration_date":"2032-04-24","underlying":"Common Stock","underlying_shares":1326000},"source":{"system":"sec-edgar","filing":"0000899243-22-031348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000089924322031348/doc4.xml","form_type":"4"}},{"id":2157314,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option - Option to buy","published_at":"2022-09-16T18:00:32.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,910 shares of Syros common stock for $32.63 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,910 shares of Syros common stock for $32.63 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":1.43,"expiration_date":"2031-06-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-22-031348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000089924322031348/doc4.xml","form_type":"4"}},{"id":2157313,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option - Option to buy","published_at":"2022-09-16T18:00:32.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was fully vested and assumed by Syros Pharmaceuticals, Inc. (\"Syros\") in its merger with the issuer and replaced with an option to purchase 87,640 shares of Syros common stock for $23.51 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the \"Reverse Split\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was fully vested and assumed by Syros Pharmaceuticals, Inc. (\"Syros\") in its merger with the issuer and replaced with an option to purchase 87,640 shares of Syros common stock for $23.51 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the \"Reverse Split\")."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000899243-22-031348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000089924322031348/doc4.xml","form_type":"4"}},{"id":2290274,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option - Option to buy","published_at":"2022-04-26T16:05:27.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":1326000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a four-year period in equal quarterly installments."}],"balance_after":1326000,"derivative":{"exercise_price":0.33,"expiration_date":"2032-04-25","underlying":"Common Stock","underlying_shares":1326000},"source":{"system":"sec-edgar","filing":"0000899243-22-015652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000089924322015652/doc4.xml","form_type":"4"}},{"id":2666306,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option - Option to buy","published_at":"2021-06-16T16:24:10.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a four-year period in equal quarterly installments."}],"balance_after":500000,"derivative":{"exercise_price":1.43,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-21-024144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000089924321024144/doc4.xml","form_type":"4"}},{"id":2964215,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option - Option to buy","published_at":"2020-11-30T16:10:08.000Z","date":"2020-11-25","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a four-year period in equal quarterly installments."}],"balance_after":2000000,"derivative":{"exercise_price":1.03,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000899243-20-032299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000089924320032299/doc4.xml","form_type":"4"}},{"id":3544376,"issuer":{"id":155263,"kind":"organization","name":"Icagen, Inc.","symbol":"NONE"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-05-01T18:25:37.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":154616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest in full immediately upon the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in full immediately upon the date of the grant."}],"balance_after":154616,"derivative":{"exercise_price":3.5,"exercise_date":"2019-04-29","expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":154616},"source":{"system":"sec-edgar","filing":"0001213900-19-007622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000121390019007622/ownership.xml","form_type":"4"}},{"id":3761066,"issuer":{"id":155263,"kind":"organization","name":"Icagen, Inc.","symbol":"NONE"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-11-16T16:18:29.000Z","date":"2018-11-14","kind":"grant","acquired":true,"shares":535000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vest on pro rata on a monthly basis over three years commencing on November 30, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vest on pro rata on a monthly basis over three years commencing on November 30, 2018."}],"balance_after":535000,"derivative":{"exercise_price":3.5,"exercise_date":"2018-11-14","expiration_date":"2028-11-14","underlying":"Common Stock","underlying_shares":535000},"source":{"system":"sec-edgar","filing":"0001213900-18-016061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000121390018016061/ownership.xml","form_type":"4"}},{"id":4117242,"issuer":{"id":155263,"kind":"organization","name":"Icagen, Inc.","symbol":"NONE"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant","published_at":"2018-01-02T17:08:19.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":5357,"price":0.02,"value":107.14,"ownership":{"direct":true},"balance_after":5357,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-29","expiration_date":"2019-12-31","underlying":"Common Stock","underlying_shares":5357},"source":{"system":"sec-edgar","filing":"0001213900-18-000048","document":"f4122917cunningham_icagen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000121390018000048/f4122917cunningham_icagen.xml","form_type":"4"}},{"id":4117241,"issuer":{"id":155263,"kind":"organization","name":"Icagen, Inc.","symbol":"NONE"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-01-02T17:08:19.000Z","date":"2017-12-29","kind":"purchase","acquired":true,"shares":21428,"price":0.37,"value":7928.36,"ownership":{"direct":true},"balance_after":21428,"source":{"system":"sec-edgar","filing":"0001213900-18-000048","document":"f4122917cunningham_icagen.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000121390018000048/f4122917cunningham_icagen.xml","form_type":"4"}},{"id":4382483,"issuer":{"id":155263,"kind":"organization","name":"Icagen, Inc.","symbol":"NONE"},"owners":[{"id":81022,"kind":"person","name":"Cunningham, Richard Anthony","position":1,"cik":"0001624783","reported_name":"Cunningham, Richard Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-03-16T17:01:42.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over a three year period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over a three year period."}],"balance_after":20000,"derivative":{"exercise_price":3.5,"exercise_date":"2017-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-17-002484","document":"f4031517cunningham_icageninc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624783/000121390017002484/f4031517cunningham_icageninc.xml","form_type":"4"}}]}